Who
Alfred J. Novak
Director
Company insider
Files Form 4 as: Director, Pasithea Therapeutics; Director, LivaNova; Director, Dova Pharmaceuticals; Director, Cyberonics.
In numbers
- Trades disclosed
- 66
- Buys
- 1
- Sells
- 14
- Bought
- $47K
- Sold
- $2.1M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 12 Mar 2007
- Last trade
- 1 May 2026
- Last filed
- 5 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 May 2026filed 5 May 2026 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —152,783 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —152,783 at $0.00 | filing |
| 24 Oct 2025filed 27 Oct 2025 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,913 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $15K2,750 at $5.62 | filing |
| 12 Jun 2024filed 14 Jun 2024 | KTTA Pasithea TherapeuticsBiotechnology | SEC FORM 4 Code A | $4,208750 at $5.61 | filing |
| 1 Mar 2024filed 5 Apr 2024 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 1 Mar 2024filed 1 Mar 2024 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 21 Oct 2022filed 24 Oct 2022 | KTTA Pasithea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,346 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code M | —1,346 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code F | $5,81497 at $59.94 | filing |
| 11 Nov 2021filed 12 Nov 2021 | LIVN LivaNovaMedical Devices | SEC FORM 4 Sold | $208K2,337 at $89.17 | filing |
| 10 Nov 2021filed 12 Nov 2021 | LIVN LivaNovaMedical Devices | SEC FORM 4 Sold | $58K644 at $90.77 | filing |
| 29 Jun 2021filed 1 Jul 2021 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code M | —2,337 at $0.00 | filing |
| 29 Jun 2021filed 1 Jul 2021 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,337 at $0.00 | filing |
| 15 Jun 2021filed 16 Jun 2021 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,346 at $0.00 | filing |
| 29 Jun 2020filed 1 Jul 2020 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,337 at $0.00 | filing |
| 18 Jun 2020filed 6 Nov 2020 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code F | $2,80158 at $48.29 | filing |
| 18 Jun 2020filed 22 Jun 2020 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,500 at $0.00 | filing |
| 18 Jun 2020filed 22 Jun 2020 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code M | —1,500 at $0.00 | filing |
News
Financial Comparison: LivaNova (NASDAQ:LIVN) vs. QuidelOrtho (NASDAQ:QDEL)LIVN · themarketsdaily.com · 17 Oct 2026Analyzing LivaNova (NASDAQ:LIVN) & QuidelOrtho (NASDAQ:QDEL)LIVN · themarketsdaily.com · 16 Oct 2026Financial Survey: Kewaunee Scientific (NASDAQ:KEQU) versus LivaNova (NASDAQ:LIVN)LIVN · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Alfred J. Novak; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.